Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
190%
upside
3 price targets
|
0
%
|
|
|
|
190%
upside
3 price targets
|
0
%
|
|
|
|
190%
upside
5 price targets
|
0
%
|
|
|
29
SAB Biotherapeutics
SABS
$195M
|
176%
upside
3 price targets
|
0
%
|
|
|
171%
upside
3 price targets
|
0
%
|
|
|
|
170%
upside
3 price targets
|
0
%
|
|
|
|
169%
upside
3 price targets
|
0
%
|
|
|
|
168%
upside
5 price targets
|
0
%
|
|
|
|
164%
upside
3 price targets
|
0
%
|
|
|
|
162%
upside
4 price targets
|
0
%
|
|
|
36
Wave Life Sciences
WVE
$2.59B
|
159%
upside
11 price targets
|
0
%
|
|
|
158%
upside
3 price targets
|
0
%
|
|
|
|
156%
upside
5 price targets
|
0
%
|
|
|
|
155%
upside
7 price targets
|
0
%
|
|
|
|
149%
upside
5 price targets
|
0
%
|
|
|
|
147%
upside
4 price targets
|
0
%
|
|
|
|
145%
upside
4 price targets
|
0
%
|
|
|
|
145%
upside
11 price targets
|
0
%
|
|
|
|
144%
upside
3 price targets
|
0
%
|
|
|
|
143%
upside
4 price targets
|
0
%
|
|
|
|
142%
upside
3 price targets
|
0
%
|
|
|
|
138%
upside
7 price targets
|
0
%
|
|
|
|
138%
upside
3 price targets
|
0
%
|
|
|
|
137%
upside
3 price targets
|
0
%
|
|
|
|
136%
upside
13 price targets
|
0
%
|
|